Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Chloral Hydrate
Total 0 results
Nothing found
Sponsors and Collaborators
RMIT University, Melbourne, Australia
Eurofins Genoma
Nacuity Pharmaceuticals, Inc.
ASST Cremona, Cremona
iCAD
Everett Meyer
GFI
Kupfer, David J., M.D.
Hospital ASEPEYO Sant Cugat
Apollo Neuroscience, Inc.
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Hospital Durand, Argentina
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Agency for Science, Technology and Research
Alma Lasers Inc.
Mª Victoria Maestre Sanchez
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Korean Society of Spine Surgery
Aptis Medical
Neurophth Therapeutics Inc
View Full List
Medical Conditions
Treatment Decisions
Splenic Trauma
Scleredema
RISS Stage III Plasma Cell Myeloma
Fever
Disorder of Fluid Balance
T-LGL Leukemia
Dienogest
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Major Liver Surgery
Chronic Constipation Symptoms
Gastric Cancer Stage IIIB-IIIC
Metachronous Adenoma
Recurrent Clear Cell Sarcoma of Soft Tissue
Immune-Mediated Inflammatory Disease
The Strength Properties of the Aorta in Vitro
Corneal Cross-Linking
Luteal Phase Support
Rheumatoid Arthritis(RA)
View Full List
Drug Interventions
MLN2480
Intravenous deferiprone
Capecitabine/cisplatin
Desvenlafaxine
Camptosar
Midazolam
RDX227675
TPN-101
Olopatadine
Anticholinergic
Letrozole
Capecitabine and IMRT (if randomized to this arm)
GLPG1837 multiple ascending doses
Oxycodone/acetaminophen 5/325 mg
THC
OnabotulinumtoxinA
Standard of care (SOC) for COVID-19
PD-1/PD-L1 inhibitor
Fospropofol disodium, propofol
Intravenous Formulation of PD-0332991
View Full List
CROs by country
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Croatia
Contract Research Organizations in Ecuador
Contract Research Organizations in El Salvador
Contract Research Organizations in Gabon
Contract Research Organizations in Georgia
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Norway
Contract Research Organizations in Qatar
Contract Research Organizations in Singapore
Contract Research Organizations in Tunisia
Contract Research Organizations in Uganda
Contract Research Organizations in Vietnam
CRO list by country
CROs in Equatorial Guinea
SGS
All CROs in Equatorial Guinea
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe